Mohammed Alomar
YOU?
Author Swipe
View article: Assessment of Intra-Individual Variability and Reproducibility in Pancreatic EUS-Guided Elastography
Assessment of Intra-Individual Variability and Reproducibility in Pancreatic EUS-Guided Elastography Open
Background: Shear-wave elastography (SWE) performed during endoscopic ultrasound (EUS) is a promising tool for quantifying pancreatic stiffness, but its intra-session reproducibility remains incompletely defined. Methods: In this prospecti…
View article: Methylation-based biological age and cardiotoxicity risk in breast cancer patients treated with trastuzumab
Methylation-based biological age and cardiotoxicity risk in breast cancer patients treated with trastuzumab Open
Pre-treatment epigenetic age acceleration appears to be a novel biomarker for cardiotoxicity risk that improves cardiotoxicity risk prediction.
View article: Cardiovascular adverse events and outcomes after anti-BCMA CAR-T for relapsed and refractory multiple myeloma
Cardiovascular adverse events and outcomes after anti-BCMA CAR-T for relapsed and refractory multiple myeloma Open
View article: Metabolomic signatures of carfilzomib‐related cardiotoxicity in patients with multiple myeloma
Metabolomic signatures of carfilzomib‐related cardiotoxicity in patients with multiple myeloma Open
As a treatment for relapsed or refractory multiple myeloma (MM), carfilzomib has been associated with a significant risk of cardiovascular adverse events (CVAE). The goals of our study were to evaluate the metabolomic profile of MM patient…
View article: Metabolomic signatures of carfilzomib‐related cardiotoxicity in patients with multiple myeloma
Metabolomic signatures of carfilzomib‐related cardiotoxicity in patients with multiple myeloma Open
As a treatment for relapsed or refractory multiple myeloma (MM), carfilzomib has been associated with a significant risk of cardiovascular adverse events (CVAE). The goals of our study were to evaluate the metabolomic profile of MM patient…
View article: Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma
Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma Open
Background Percutaneous Hepatic Perfusion (PHP) is a liver directed regional therapy recently FDA approved for metastatic uveal melanoma to the liver involving percutaneous isolation of liver, saturation of the entire liver with high-dose …
View article: Unveiling the Cardiotoxicity Conundrum: Navigating the Seas of Tyrosine Kinase Inhibitor Therapies
Unveiling the Cardiotoxicity Conundrum: Navigating the Seas of Tyrosine Kinase Inhibitor Therapies Open
Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of various solid and hematologic malignancies by targeting dysregulated signaling pathways critical for malignant cell growth. However, these therapeutic benefits are ofte…
View article: Guarding the Heart in an Era of “Tachy-CAR-T”
Guarding the Heart in an Era of “Tachy-CAR-T” Open
View article: Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma
Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma Open
Idecabtagene vicleucel (ide-cel) is a type of B-cell maturation antigen (BCMA)–targeting chimeric antigen receptor T-cell (CAR-T) approved for the treatment of relapsed and refractory multiple myeloma (RRMM). Currently, the incidence of ca…
View article: Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study
Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study Open
Background Chimeric antigen receptor T- Cell (CAR-T) immunotherapy has been a breakthrough treatment for various hematological malignancies. However, cardiotoxicities such as new-onset heart failure, arrhythmia, acute coronary syndrome and…
View article: Case of Myocarditis After Chimeric Antigen Receptor T Cells With Intracardiac Lymphoma
Case of Myocarditis After Chimeric Antigen Receptor T Cells With Intracardiac Lymphoma Open
Chimeric antigen receptor T cells (CAR-T) therapy is a novel therapeutic approach that modifies T cells to attack cancer cells, including lymphoma. We present a case of large B cell lymphoma with intracardiac involvement treated with CAR-T…
View article: Global pattern of cardiovascular disease management in patients with cancer and impact of COVID-19 on drug selection: IRAQ—IC-OS survey-based study
Global pattern of cardiovascular disease management in patients with cancer and impact of COVID-19 on drug selection: IRAQ—IC-OS survey-based study Open
Background Regional variations in cardiovascular disease (CVD) and CVD management are well known. However, there is limited information on geographical variations in the discipline of Cardio-Oncology, including both the nature of CVD in pa…
View article: Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapy
Patient reported physical and mental health changes associated with a comprehensive cardiovascular risk reduction program for women with breast cancer receiving potentially cardiotoxic chemotherapy Open
Objective Women with breast cancer (BCA) and cardiovascular disease (CVD) risk factors are at increased risk of developing cardiovascular complications when exposed to potentially cardiotoxic cancer therapy. The benefit of aggressive CVD r…
View article: Patient Reported Physical and Mental Health Changes Associated with a Comprehensive Cardiovascular Risk Reduction Program for Women with Breast Cancer Receiving Potentially Cardiotoxic Chemotherapy
Patient Reported Physical and Mental Health Changes Associated with a Comprehensive Cardiovascular Risk Reduction Program for Women with Breast Cancer Receiving Potentially Cardiotoxic Chemotherapy Open
Objective: Women with breast cancer (BCA) and cardiovascular disease (CVD) risk factors are at increased risk of developing cardiovascular complications when exposed to potentially cardiotoxic cancer therapy. The benefit of aggressive CVD …
View article: Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter Open
Nearly one-half of patients with cancer, the majority with normal platelet counts, had an elevated risk for stroke but did not receive AC. In addition to known predictors, current chemotherapy use was independently associated with a lower …
View article: Electrophysiology Translational Considerations in Cardio-Oncology: QT and Beyond
Electrophysiology Translational Considerations in Cardio-Oncology: QT and Beyond Open
With improved screening and the advent of many novel therapeutics, patients with cancer are living longer and often surviving their disease. Cardiovascular complications have significant impact on both short- and long-term morbidity and mo…
View article: 37TH WORLD CONGRESS OF ENDOUROLOGY COMMITTEES AND AWARDS
37TH WORLD CONGRESS OF ENDOUROLOGY COMMITTEES AND AWARDS Open